Uptake and Spending on Biosimilar Infliximab and Etanercept After New Start and Switching Policies in Canada: An Interrupted Time Series Analysis.
Arthritis care & research（2023）
摘要
We found that mandatory switching policies were much more effective than new starting policies for increasing the use of biosimilar medications.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要